MX2020004844A - Procedimiento para la purificacion de un oligosacarido neutro de leche humana usando cromatografia en lecho movil simulado. - Google Patents

Procedimiento para la purificacion de un oligosacarido neutro de leche humana usando cromatografia en lecho movil simulado.

Info

Publication number
MX2020004844A
MX2020004844A MX2020004844A MX2020004844A MX2020004844A MX 2020004844 A MX2020004844 A MX 2020004844A MX 2020004844 A MX2020004844 A MX 2020004844A MX 2020004844 A MX2020004844 A MX 2020004844A MX 2020004844 A MX2020004844 A MX 2020004844A
Authority
MX
Mexico
Prior art keywords
purification
neutral
hmos
moving bed
human milk
Prior art date
Application number
MX2020004844A
Other languages
English (en)
Inventor
Stefan Jennewein
Markus Helfrich
Original Assignee
Jennewein Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49293548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2020004844(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jennewein Biotechnologie Gmbh filed Critical Jennewein Biotechnologie Gmbh
Publication of MX2020004844A publication Critical patent/MX2020004844A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1814—Recycling of the fraction to be distributed
    • B01D15/1821—Simulated moving beds
    • B01D15/185—Simulated moving beds characterised by the components to be separated
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
    • B01D61/422—Electrodialysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C07H1/08—Separation; Purification from natural products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2315/00—Details relating to the membrane module operation
    • B01D2315/16—Diafiltration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Pediatric Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Nanotechnology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)

Abstract

La presente solicitud divulga un proceso para la purificación de un oligosacárido neutro de leche humana (OLH neutro). El procedimiento usa cromatografía en lecho móvil simulado (LMS) que permite la purificación continua de grandes cantidades de OLH de alta pureza. Al contrario que las vías de síntesis química de los OLH neutros, y de su posterior purificación, el procedimiento presentado permite la provisión de OLH sin sustancias químicas nocivas, tales como p.ej., trazas de metales pesados o disolventes orgánicos. El producto de OLH neutro individual puede obtenerse en forma sólida mediante deshidratación por pulverización o como un jarabe concentrado. El OLH neutro proporcionado es muy adecuado para su uso en aplicaciones alimentarias.
MX2020004844A 2013-10-04 2016-04-01 Procedimiento para la purificacion de un oligosacarido neutro de leche humana usando cromatografia en lecho movil simulado. MX2020004844A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13187369.7A EP2857410A1 (en) 2013-10-04 2013-10-04 Process for purification of 2´-fucosyllactose using simulated moving bed chromatography

Publications (1)

Publication Number Publication Date
MX2020004844A true MX2020004844A (es) 2020-10-20

Family

ID=49293548

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016004288A MX373919B (es) 2013-10-04 2014-10-02 Procedimiento para la purificacion de un oligosacarido neutro de leche humana usando cromatografia en lecho movil simulado.
MX2020004844A MX2020004844A (es) 2013-10-04 2016-04-01 Procedimiento para la purificacion de un oligosacarido neutro de leche humana usando cromatografia en lecho movil simulado.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016004288A MX373919B (es) 2013-10-04 2014-10-02 Procedimiento para la purificacion de un oligosacarido neutro de leche humana usando cromatografia en lecho movil simulado.

Country Status (13)

Country Link
US (2) US10435427B2 (es)
EP (2) EP2857410A1 (es)
JP (1) JP6666243B2 (es)
KR (1) KR102298281B1 (es)
CN (2) CN105814070A (es)
BR (1) BR112016007342B1 (es)
DK (1) DK3063159T3 (es)
ES (1) ES2868249T3 (es)
MX (2) MX373919B (es)
PH (1) PH12016500594B1 (es)
PL (1) PL3063159T3 (es)
RU (1) RU2685537C2 (es)
WO (1) WO2015049331A1 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2857410A1 (en) 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
DK2896628T3 (en) 2014-01-20 2019-01-14 Jennewein Biotechnologie Gmbh Process for Effective Purification of Neutral Milk Oligosaccharides (HMOs) from Microbial Fermentation
WO2016063262A1 (en) 2014-10-24 2016-04-28 Glycom A/S MIXTURES OF HMOs
US10829508B2 (en) 2015-12-18 2020-11-10 Glycom A/S Fermentative production of oligosaccharides
EP4674526A3 (en) 2016-04-19 2026-04-01 Glycom A/S Separation of oligosaccharides from fermentation broth
EP3474861A4 (en) 2016-06-24 2020-04-15 Glycom A/S COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
KR101979608B1 (ko) * 2017-04-17 2019-08-28 재단법인 탄소순환형 차세대 바이오매스 생산전환 기술연구단 푸코오스 분리방법 및 이를 위한 장치
US20200305488A1 (en) * 2017-07-07 2020-10-01 Societe Des Produitis Nestle S.A. Human milk fortifier
CN110914284B (zh) 2017-07-12 2025-01-07 格礼卡姆股份公司 包含中性单糖或寡糖和酸性非碳水化合物组分的无定形混合物
EP3450443A1 (en) * 2017-08-29 2019-03-06 Jennewein Biotechnologie GmbH Process for purifying sialylated oligosaccharides
WO2019050321A1 (ko) * 2017-09-07 2019-03-14 (주)프로테옴텍 다수의 검사선을 구비한 크로마토그래피용 스트립, 이를 포함하는 진단 키트 및 다수의 경쟁적 반응 측정 단계를 포함하는 정성, 반정량, 정량 분석방법
EP3688005A1 (en) * 2017-09-29 2020-08-05 FrieslandCampina Nederland B.V. Process for the purification of a neutral human milk oligosaccharide (hmo) from microbial fermentation
KR20200096779A (ko) * 2017-12-08 2020-08-13 젠와인 바이오테크놀로지 게엠바하 분무건조된 인간 모유 올리고당 혼합물
EP3494807A1 (en) 2017-12-11 2019-06-12 Jennewein Biotechnologie GmbH Spray-dried sialyllactose
EP3494804B1 (en) 2017-12-08 2025-08-13 Chr. Hansen HMO GmbH Spray-dried 3-fucosyllactose
ES3040419T3 (en) 2017-12-08 2025-10-30 Chr Hansen Hmo Gmbh Spray-dried lacto-n-fucopentaose
PL3494805T3 (pl) 2017-12-08 2025-10-06 Chr. Hansen HMO GmbH Suszone rozpyłowo tetrasacharydy
PL3524067T3 (pl) 2018-02-08 2025-06-09 Chr. Hansen HMO GmbH Suszona rozpyłowo mieszanina oligosacharydów mleka ludzkiego
WO2019160922A1 (en) * 2018-02-19 2019-08-22 Dupont Nutrition Biosciences Aps Process for spray drying fucosyllactose solutions and related product compositions
EP3546060A1 (en) * 2018-03-27 2019-10-02 DuPont Nutrition Biosciences ApS Process for spray drying fucosyllactose solutions and related product compositions
JP7492458B2 (ja) * 2018-05-07 2024-05-29 クリスチャン・ハンセン・ハーエムオー・ゲーエムベーハー 微生物発酵によって得られた炭水化物からラクト－Ｎ－ネオテトラオース（ＬＮｎＴ）を精製するための簡素な方法
CN112154150A (zh) * 2018-05-23 2020-12-29 帝斯曼知识产权资产管理有限公司 寡糖的生产
CN112888317A (zh) * 2018-08-08 2021-06-01 马斯公司 含低聚糖的宠物食品及使用方法
WO2020079146A1 (en) 2018-10-18 2020-04-23 Basf Se Crystalline form ii of 2'-o-fucosyllactose, process for its preparation, nutritional, cosmetic or pharmaceutical formulation containing the same
WO2020128945A1 (en) 2018-12-19 2020-06-25 Glycom A/S Separation of oligosaccharides
EP3741770A1 (en) * 2019-05-21 2020-11-25 Jennewein Biotechnologie GmbH Purification of oligosaccharides from a fermentation broth by using filtration
EP3750902A1 (en) * 2019-06-14 2020-12-16 Jennewein Biotechnologie GmbH Process for the purification of lacto-n-neotetraose
US20220273016A1 (en) * 2019-07-18 2022-09-01 The Regents Of The University Of California Human milk oligosaccharides for control of dietary response and metabolic phenotype
TW202126317A (zh) 2019-09-24 2021-07-16 美商普拉塔生技公司 用於治療發炎和免疫疾病之組成物和方法
CN110672756B (zh) * 2019-11-07 2020-12-29 江南大学 一种奶粉中2’-岩藻糖基乳糖含量的检测方法
US20230074506A1 (en) * 2020-01-29 2023-03-09 Dsm Ip Assets B.V. Process for recovering & purifying human milk oligosaccharides
BR112022018578A2 (pt) * 2020-03-20 2022-11-08 Glycom As Métodos para fornecer um produto de hmo sólido e produtos de hmo sólido obtidos por meio deles
WO2021250191A1 (en) * 2020-06-12 2021-12-16 Basf Se Improved demineralization of fermentation broths and purification of fine chemicals such as oligosaccharides
CA3188645A1 (en) 2020-08-14 2022-02-17 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies
CN112526022A (zh) * 2020-11-27 2021-03-19 内蒙古伊利实业集团股份有限公司 一种乳中母乳低聚糖的检测方法
EP4277634A1 (en) 2021-01-12 2023-11-22 Prolacta Bioscience, Inc. Synbiotic treatment regimens
CN116940244A (zh) 2021-03-09 2023-10-24 菲仕兰坎皮纳荷兰公司 包含gos和hmo的水性组合物
CN117651602A (zh) * 2021-06-15 2024-03-05 帝斯曼知识产权资产管理有限公司 从发酵液中分离人乳寡糖
EP4418878A1 (en) * 2021-10-18 2024-08-28 DSM IP Assets B.V. A method for providing an amorphous hmo product by drying
CN117003803A (zh) 2022-05-07 2023-11-07 山东恒鲁生物科技有限公司 一种三糖的新晶型
CN115873051B (zh) 2022-05-17 2024-06-25 山东恒鲁生物科技有限公司 三糖的新晶型
CN115073539B (zh) * 2022-07-21 2023-06-16 南京工业大学 一种2’-岩藻糖基乳糖分离纯化的方法
CN115260255B (zh) * 2022-08-30 2024-06-28 南京工业大学 一种利用模拟移动床分离纯化2’-岩藻糖基乳糖的方法
WO2024130119A2 (en) 2022-12-16 2024-06-20 Prolacta Bioscience, Inc. Synbiotic compositions for short chain fatty acid production
CN115856151B (zh) * 2022-12-27 2025-08-12 深圳市中科朗健生物技术有限公司 一种同时测定多种人乳低聚糖的高效液相色谱检测方法
US20240218084A1 (en) * 2022-12-28 2024-07-04 Heilongjiang Bayi Agricultural University Method for purifying fomes officinalis polysaccharide by sequential simulated moving chromatography
CN115838390A (zh) * 2022-12-30 2023-03-24 保龄宝生物股份有限公司 一种利用三组分色谱分离技术制备高含量2′-岩藻糖基乳糖的方法
WO2024165630A1 (en) * 2023-02-07 2024-08-15 N.V. Nutricia Nutritional composition with improved segregation resistance
KR20260002698A (ko) * 2023-04-19 2026-01-06 시에이치알. 한센 에이/에스 인간 모유 올리고당
WO2025056571A1 (en) 2023-09-12 2025-03-20 Frieslandcampina Nederland B.V. Milk extracellular vesicle enrichment process
CN117089503B (zh) 2023-10-17 2024-01-02 保龄宝生物股份有限公司 一种大肠杆菌k-12 mg1655 blbyzt6及其应用
WO2025149372A1 (en) 2024-01-09 2025-07-17 Frieslandcampina Nederland B.V. Milk extracellular vesicle enrichment process using peg
CN119192253B (zh) * 2024-09-06 2025-10-21 虹摹生物科技(上海)有限公司 一种岩藻糖基乳糖及其纯化方法
CN120847064B (zh) * 2025-09-23 2025-12-05 吉林省科技创新研究院有限公司 一种液体中微量可见异物分析鉴定方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0779800B2 (ja) 1986-01-23 1995-08-30 オムロン株式会社 電子血圧計
JPH0639206B2 (ja) 1988-04-18 1994-05-25 田村プラスチック製品株式会社 ルーフバイザーの取り付け方法
JPH02286695A (ja) 1989-04-28 1990-11-26 Sumitomo Heavy Ind Ltd オリゴ糖の分離方法
NZ240002A (en) * 1991-09-30 1993-11-25 Lactose Co Of Nz Ltd Method of producing a dry powder containing lactose and "oligosaccharides"
JPH0779927B2 (ja) 1992-05-22 1995-08-30 川崎重工業株式会社 擬似移動床式液体クロマトオリゴ糖分離装置
JPH06253879A (ja) 1993-03-01 1994-09-13 Snow Brand Milk Prod Co Ltd グルクロン酸結合オリゴ糖の分離方法
DE4326665C2 (de) * 1993-08-09 1995-07-13 Biotest Pharma Gmbh Verfahren zur Sterilfiltration von Milch
JP3368389B2 (ja) 1993-09-14 2003-01-20 雪印乳業株式会社 シアル酸含有オリゴ糖の分離方法
FI962204A0 (fi) * 1996-05-24 1996-05-24 Cultor Oy Foerfarande foer fraktionering av en loesning
CN1242776A (zh) 1996-10-10 2000-01-26 尼澳斯技术股份有限公司 用超滤、反渗透和纳滤纯化糖类
HUP0001634A2 (hu) 1996-10-10 2000-09-28 Cytel Corporation Szénhidrátok tisztítása ultraszűréssel, fordított ozmózissal és nanoszűréssel
DK1531832T3 (da) 2002-06-28 2009-07-27 Glykos Finland Oy Terapeutiske sammensætninger til anvendelse ved profylakse eller behandling af diarré
EP1634599A1 (en) 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
JP5184768B2 (ja) 2006-09-05 2013-04-17 株式会社林原 トレハロース高含有糖液の回収方法並びに結晶トレハロースの製造方法
ES2656776T3 (es) 2008-06-13 2018-02-28 N.V. Nutricia Composición nutricional para bebés nacidos por cesárea
CN101367844A (zh) * 2008-09-17 2009-02-18 无锡绿色分离应用技术研究所有限公司 一种从阿拉伯胶水解液中提取阿拉伯糖的方法
AU2010233770A1 (en) 2009-04-07 2011-10-27 Glycom A/S Novel method for the synthesis of a trisaccharide
DK2440661T3 (en) * 2009-06-08 2018-03-12 Jennewein Biotechnologie Gmbh HMO synthesis
CN101831475A (zh) * 2010-03-24 2010-09-15 方煜宇 一种生产高纯度低聚半乳糖的方法
US8889637B2 (en) * 2010-06-01 2014-11-18 Glycom A/S Polymorphs of 2′-O-fucosyllactose and producing thereof
EP2465507A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
EP2675899A4 (en) 2011-02-16 2014-09-10 Glycosyn LLC BIOSYNTHESIS OF HUMAN MILK OLIGOSACCHARIDES IN MANIPULATED BACTERIA
CN102676604A (zh) * 2011-03-08 2012-09-19 保龄宝生物股份有限公司 一种连续模拟移动床色谱分离制备高纯度低聚半乳糖的方法
JP2014513985A (ja) * 2011-05-13 2014-06-19 グリコム アー／エス 人乳オリゴ糖（ｈｍｏ）又はその前駆体の形成方法
JP6129821B2 (ja) * 2011-05-13 2017-05-17 グリコシン リミテッド ライアビリティー カンパニー プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用
JP6106160B2 (ja) * 2011-05-13 2017-03-29 グリコム アー／エスＧｌｙｃｏｍ Ａ／Ｓ 人乳オリゴ糖（ｈｍｏ）又はその前駆体の多様化
EP2526784A1 (en) * 2011-05-24 2012-11-28 Nestec S.A. Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition
CN104428307A (zh) * 2012-06-14 2015-03-18 格礼卡姆股份公司 增强人乳寡糖或其前体或掺合物的稳定性和纯度以及增加其生物利用度
CN103113422B (zh) * 2013-02-06 2015-06-10 广西轻工业科学技术研究院 一种用模拟流动床分离精制高纯度l-阿拉伯糖、d-木糖的方法
EP2857410A1 (en) 2013-10-04 2015-04-08 Jennewein Biotechnologie GmbH Process for purification of 2´-fucosyllactose using simulated moving bed chromatography

Also Published As

Publication number Publication date
DK3063159T3 (da) 2021-05-10
JP6666243B2 (ja) 2020-03-13
EP2857410A1 (en) 2015-04-08
ES2868249T3 (es) 2021-10-21
EP3063159A1 (en) 2016-09-07
RU2016109548A (ru) 2017-11-09
BR112016007342A2 (pt) 2017-08-01
PH12016500594B1 (en) 2023-10-20
MX2016004288A (es) 2017-01-18
JP2016535724A (ja) 2016-11-17
US20160237104A1 (en) 2016-08-18
US11168105B2 (en) 2021-11-09
MX373919B (es) 2020-07-13
BR112016007342B1 (pt) 2020-11-17
US10435427B2 (en) 2019-10-08
CN109705175B (zh) 2022-07-05
KR102298281B1 (ko) 2021-09-07
CN109705175A (zh) 2019-05-03
KR20160090791A (ko) 2016-08-01
EP3063159B1 (en) 2021-04-07
US20190292211A1 (en) 2019-09-26
WO2015049331A1 (en) 2015-04-09
RU2016109548A3 (es) 2018-06-25
RU2685537C2 (ru) 2019-04-22
PH12016500594A1 (en) 2016-06-13
PL3063159T3 (pl) 2021-07-19
CN105814070A (zh) 2016-07-27

Similar Documents

Publication Publication Date Title
MX2020004844A (es) Procedimiento para la purificacion de un oligosacarido neutro de leche humana usando cromatografia en lecho movil simulado.
CL2014001044A1 (es) Composicion pesticida que comprende compuestos derivados de piridinas; procesos relacionados con las mismas.
EA201591527A1 (ru) Новые производные пиридина
MX2016004946A (es) Procesos para la preparacion de compuestos plaguicidas.
EA201892050A1 (ru) Способ получения замещенных 5-фтор-1h-пиразолопиридинов
FR3008412B1 (fr) Procede de transformation de biomasses lignocellulosiques en molecules mono ou poly-oxygenees
BR112018013249A2 (pt) método de preparação de compostos de carboxilado de piridil pirraglidinona
EP3353228A4 (en) POLYMERS WITH CYCLOBUTANEDIOL AND 2,2-BIS (HYDROXYMETHYL) ALKYL ACOBLIC ACID
WO2016106094A3 (en) Metal-organic frameworks for the conversion of lignocellulosic derivatives to renewable platform chemicals
BR112017011285A2 (pt) compostos intermediários para produzir ingredientes de perfumaria
RU2013138082A (ru) Способ получения препарата для обработки плодоовощной продукции
CL2014000140A1 (es) Uso de anolito neutro para descontaminar troncos de vid; procedimiento para producir planta de vid injerto-soldada que comprende aplicar dicho anolito neutro.
FR2996548B1 (fr) Procede de traitement en continu d'une eau contenant de la matiere organique par traitement enzymatique.
CY1118806T1 (el) Υποκατεστημενα χρωμαν-6-υλοξυ-κυκλοαλκανια και η χρηση τους ως φαρμακευτικες ουσιες
EA201690547A1 (ru) Сельскохозяйственные химические продукты
FR3039150B1 (fr) Procede de production de 5-hydroxymethylfurfural en presence de catalyseurs organiques de la famille des thiourees
WO2015000555A3 (en) A novel process for the preparation of tetralin and naphthalene derivatives
FR3044311B1 (fr) Procede de synthese de derives n-(pyridin-4-yl)-2-hydroxy-alkylamides enantiomeriquement purs
FR3039077B1 (fr) Procede de conversion de biomasse en huile faiblement oxygenee
NI201400017A (es) 2 - (croman - 6 - iloxi ) - tiazoles sustituidos y su uso como productos farmacéuticos
UY35503A (es) Titulo: procedimiento de síntesis de derivados de la 7,8-dimetoxi-1,3 -dihidro-2h-3- benzazepin -2- ona y aplicación a la síntesis de la ivabradina
FR3003261B1 (fr) Procede de synthese d'oligomeres de glycerol acyles
PL403740A1 (pl) Nowe pochodne pirolu i sposób ich wytwarzania
PL398858A1 (pl) Sposób wydzielania substancji biologicznie czynnych z soku kapusty
UA110455C2 (en) METHOD FOR SPIRO-λ6-IZOTIAZOLIDYN-1,1,4-TRION

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: CURADIGM SAS